Acupuncture for Peripheral Neuropathy
An evidence-based overview of how acupuncture is used to treat the nerve pain, numbness, and tingling of peripheral neuropathy, what the research supports, where it falls short, and what treatment actually involves.
On this page
What peripheral neuropathy is
Symptoms and the stocking-and-glove pattern
The four most common types
Why it is difficult to treat
How acupuncture is thought to work
What the research shows
What the evidence does and does not show
What treatment typically involves
What to expect during recovery
Self-care that supports treatment
Safety
The bottom line
References
What peripheral neuropathy is
Peripheral neuropathy is damage to the peripheral nerves, the network that carries signals between the central nervous system (the brain and spinal cord) and the rest of the body. When these nerves are injured, the signals they carry become weakened, distorted, or lost. The result is most often numbness, tingling, burning, or pain, usually beginning in the feet and hands. An estimated 20 million or more people in the United States live with some form of peripheral neuropathy, and its most common forms primarily affect the sensory nerves, the fibers responsible for sensations such as touch, temperature, and pain. For that reason, the conditions discussed here belong to a category clinicians call distal sensory polyneuropathy (DSP): distal because symptoms start at the far ends of the body, sensory because they mainly affect sensation, and polyneuropathy because many nerves are involved at once. One useful starting point: regardless of what first injures a nerve, diabetes, chemotherapy, or an unknown cause, the resulting nerve damage tends to follow similar patterns. This is part of why a fairly consistent treatment approach can be applied across different types of neuropathy, even though, as we'll see, how well each type responds can differ. In brief Peripheral neuropathy is damage to the peripheral nerves that produces numbness, tingling, burning, and pain, usually starting in the feet. Its most common forms primarily affect the sensory nerves.
Symptoms and the stocking-and-glove pattern
Because the longest nerves in the body are usually affected first, symptoms typically begin in the toes and the balls of the feet, then move slowly upward toward the ankles and lower legs over time. The hands may follow. This produces the characteristic "stocking-and-glove" distribution, symptoms map onto roughly the area a sock or a glove would cover. Common sensory symptoms include:
Numbness or reduced sensation
Tingling or "pins and needles"
Burning or shooting pain
Heightened sensitivity, where even light touch, a bedsheet against the feet, can feel painful
Loss of balance, clumsiness, and unsteadiness when walking
Loss of fine motor skills, such as buttoning a shirt or picking up small objects Clinicians use precise terms to describe these altered sensations, which can be helpful to recognize:
Paresthesia: tingling or "pins and needles," often with no outside trigger.
Dysesthesia: unpleasant or painful abnormal sensations, such as burning.
Allodynia: pain from something that should not hurt, like a light touch or a bedsheet.
Hypoesthesia: reduced sensation, or numbness. When to see a doctor Have persistent tingling, numbness, weakness, or pain in your hands or feet evaluated by a physician. Early diagnosis offers the best chance to identify and address an underlying cause before nerve damage progresses. Reduced sensation in the feet deserves particular attention, because it can hide injuries and lead to unnoticed wounds.
The four most common types
Most cases of distal sensory polyneuropathy fall into four categories. They differ in cause, but share the same general pattern of nerve damage.
Diabetic Peripheral Neuropathy (DPN)
The most common form. Roughly half of people with diabetes aged 65 and older develop diabetic neuropathy. Chronically elevated blood sugar damages both the small blood vessels that nourish the nerves and the nerve fibers themselves. Because reduced sensation can mask injuries, diabetic neuropathy is a leading contributor to foot ulcers and lower-limb amputations, which is why preserving sensation, not just easing pain, is an important clinical goal.
Chemotherapy-induced Peripheral Neuropathy (CIPN)
A common, and sometimes "dose-limiting", side effect of several chemotherapy drug classes, including platinum compounds, taxanes, and vinca alkaloids. Symptoms often begin within the first two months of treatment, can affect the hands and feet at the same time, and may intensify as cumulative drug doses rise. In some people symptoms ease after chemotherapy ends; in others they persist long after.
Idiopathic Peripheral Neuropathy
When no cause can be found after a thorough evaluation, the neuropathy is called idiopathic (sometimes chronic idiopathic axonal polyneuropathy, or CIAP). It accounts for roughly a third of cases and typically appears in the sixth decade of life or later, developing gradually over months to years. Muscle strength usually remains intact.
HIV/AIDS-associated distal sensory polyneuropathy
Nerve damage can result both from HIV itself and from some antiretroviral medications. As survival with HIV has improved, this form has become more relevant. In one large cohort, about a third of participants had peripheral neuropathy and roughly 9% had symptomatic neuropathy, with older age, antiretroviral use, and a history of diabetes among the associated factors.[7]
Why it is difficult to treat
Two features make these conditions genuinely challenging to treat.
The nerves involved are the longest in the body
Neuropathy of this kind is length-dependent. The nerves that reach the feet are the body's longest, which makes them the most exposed to metabolic and toxic stress and the first to show damage. During recovery, they are often the last to fully regain function. This is why symptoms start at the toes, and why improvement, when it happens, tends to move from the more central areas outward toward the extremities.
Response depends heavily on the cause
How well neuropathy responds to treatment of any kind varies by type:
Idiopathic neuropathy tends to respond comparatively well.
Diabetic neuropathy generally responds when blood sugar is reasonably controlled. Poorly controlled blood sugar both worsens the condition and limits how much any treatment can achieve.
Chemotherapy-induced neuropathy can be the most difficult, because the injury comes from direct neurotoxic damage that may continue for as long as treatment does.
HIV-associated neuropathy is thought to be similar in difficulty, and is the least studied of the four. Conventional management works on two fronts: treating the underlying cause where possible (for example, blood sugar control in diabetes), and managing symptoms, often with medications such as certain antidepressants (SNRIs like duloxetine), gabapentinoids, or topical agents. These can reduce pain, but they manage symptoms rather than repair the underlying nerve damage, and they carry their own side effects. That gap, symptom control without nerve repair, is part of what has driven interest in additional approaches, including acupuncture.
How acupuncture is thought to work
Acupuncture involves inserting very thin needles into specific points on the body. For peripheral neuropathy, researchers have proposed several ways it may help, though the full picture is still being worked out:
Improving blood supply (microcirculation) to nerves and reducing inflammation around damaged fibers.
Modulating pain signaling in both the peripheral and central nervous systems.
Possibly supporting the nerve's own repair processes, the most provocative, and least settled, hypothesis. It's worth being precise about that last point. The idea that acupuncture might support nerve regeneration comes largely from studies showing measurable improvements in nerve conduction, an objective, electrical measurement of how well a nerve carries signals, after a course of treatment. Improved conduction is consistent with nerves recovering function. But it is an inference about the underlying biology, not a direct observation of regrown nerve fibers. That distinction matters, and we return to it below.
What the research shows
Over the past two decades, a growing body of research, including randomized controlled trials, the most rigorous study design, and systematic reviews that pool many trials together, has examined acupuncture for peripheral neuropathy. A handful of studies stand out, both for their findings and for what they chose to measure.
The ACUDIN trial (2021)
One of the most methodologically careful trials to date. This randomized, partially double-blinded, placebo-controlled study assigned adults with confirmed type 2 diabetic neuropathy to needle acupuncture, laser acupuncture, or placebo laser, with ten weekly sessions. Of 180 participants, 172 completed the study. Compared with placebo, needle acupuncture significantly improved nerve-conduction measures, including the sural sensory nerve action potential and nerve conduction velocities, and improved patient-reported symptoms such as heightened sensitivity and cramps. The authors concluded that needle acupuncture had significant effects, and that the conduction improvements "presumably" indicate structural nerve regeneration. (That careful word is worth noting, see the next section.) Meyer-Hamme G, Friedemann T, Greten J, Gerloff C, Schroeder S. Journal of Diabetes, 2021.1
Schröder and colleagues (2007)
Likely the first trial to use nerve conduction studies as its primary measure of success. Forty-seven patients with nerve-conduction-confirmed idiopathic neuropathy received weekly treatment over ten weeks. By week 10, sixteen of twenty-one patients in the acupuncture group, about 76%, showed measurable improvement in nerve conduction, and roughly a third reported symptom relief after only one or two sessions. Schröder S, et al. European Journal of Neurology, 2007.2
Reducing numbness, not just pain (2023)
A 2023 study reported roughly a 32% reduction in numbness over 8 to 16 weeks of acupuncture, with treatment well tolerated and high patient satisfaction. Its emphasis is notable: it focused on sensory loss and numbness specifically, symptoms that standard medications often do not address, rather than pain alone. World Journal of Diabetes, 2023.3
A larger but more mixed picture
CIPN has been studied more extensively, with less consistent results. A 2024 network meta-analysis of 33 randomized trials (more than 2,000 patients) found that acupuncture-based treatments improved CIPN symptoms, pain, and quality of life, with electroacupuncture appearing most effective.4 A 2022 systematic review graded the overall evidence as moderate quality and found acupuncture improved quality of life versus sham treatment, though, in one analysis, it was not significantly better than sham acupuncture for symptom relief itself.5 More recent umbrella reviews describe the evidence as promising but mixed, with benefits that are often short-term.6 Some of that inconsistency is methodological rather than biological. Many of the pooled trials delivered far fewer sessions than clinical practice considers a full course, and reviews seldom check whether the treatment dose was even adequate before including a study,[9][10] a real problem for a therapy whose proposed effect builds slowly. The comparison is imperfect too: the "sham" acupuncture used as a control is often not physiologically inert, since even off-point or non-penetrating needling stimulates sensory nerves and produces real effects, which narrows the measured gap between real and sham.[11] These are reasons to read the mixed numbers carefully, neither to dismiss them nor to over-read them.
What the evidence does and does not show
Read as a whole, the research supports some honest conclusions and leaves others genuinely open. Holding both is what keeps the picture accurate.
What the evidence reasonably supports
For diabetic and idiopathic neuropathy, multiple trials, including rigorous, sham-controlled ones, show acupuncture can improve symptoms such as pain, numbness, and tingling.
In several of these trials, improvement was measured not only by patient report but by objective nerve conduction studies, which is unusual and noteworthy for this kind of treatment.
Acupuncture has a strong safety record in these studies, with only minor side effects reported.
What remains uncertain or unproven
"Nerve regeneration" is an interpretation, not a settled fact. Improved nerve conduction is encouraging and consistent with recovery, but the studies do not directly show regrown nerve fibers, and the authors themselves use cautious language.
For chemotherapy-induced neuropathy, the evidence is more mixed: reviews are positive but graded moderate quality, and at least one sham-controlled analysis found no clear advantage over placebo acupuncture for symptoms specifically.
For HIV-associated neuropathy, there is essentially no published trial evidence as of 2026; firm conclusions can't yet be drawn.
Many individual studies are small and use different points and doses, and a convincing "placebo" needle may be impossible, because even sham needling stimulates the skin's sensory nerves and produces real effects. Both problems tend to understate acupuncture's measured effect, which is one reason careful reviews still reach cautious conclusions.[11]
On the phrase "front-line treatment"
Some organizations advocate for acupuncture to be recognized as a primary treatment for peripheral neuropathy. The Acupuncture Now Foundation, for example, has petitioned U.S. Medicare to recognize acupuncture as "reasonable and necessary" for the condition, compiling 72 studies in support.[8] That is an advocacy position, and a defensible one given the data, but it is not the same as universal endorsement by neurology guideline bodies, which to date generally treat acupuncture as a promising adjunct rather than an established standard of care. The honest summary For the most common types of peripheral neuropathy, acupuncture is a reasonable, low-risk option supported by a real and growing body of evidence, strongest for diabetic and idiopathic neuropathy, that can improve symptoms and, in some trials, measurable nerve function. It is best understood as a complement to good medical care, not a replacement for treating the underlying cause.
What treatment typically involves
Exact approaches vary from practitioner to practitioner, but treatment for peripheral neuropathy tends to share a few features.
Point selection
One standardized clinical approach targets the distal points along the nerves most affected by neuropathy. For the feet, it uses five points per leg, Liver 3, Spleen 3, Spleen 6, Spleen 9, and Stomach 36, typically needled from the most distal point upward. For the hands, a three-point approach uses Large Intestine 4, San Jiao (Triple Warmer) 5, and Large Intestine 11. As noted earlier, research has tended to converge on an overlapping set of distal points.
A built-in way to track progress
One practical feature of treating neuropathy is that the needling itself can double as a rough sensory test. Because neuropathy reduces sensation, a practitioner can note how much a patient feels at each point, sometimes recorded on a simple scale, and track those scores over time. Some practitioners informally call this a "poor man's nerve conduction test." It is not a substitute for a formal nerve conduction study, but it offers a low-cost way to monitor change from one session to the next. A common pattern: the least sensation appears at the most distal points, and often in the more severely affected limb, with sensitivity gradually returning as nerves recover. Counterintuitively, the limb that feels the least is usually the one that is more affected. Comparing total scores across visits gives a simple, trackable measure, where rising sensitivity is generally the encouraging direction.
Course of care
In research, a typical course is around ten weekly sessions. In clinical practice, many practitioners begin with two sessions per week for the first few weeks, then reduce to weekly as the patient improves, often totaling somewhere in the range of 12 to 18 sessions over 9 to 12 weeks, individualized to response. The recurring theme across the research is dosage: more treatment over a longer period tends to produce better and longer-lasting results, and stopping too early risks losing gains.
What to expect during recovery
A few patterns are worth knowing in advance, because they can be misread as setbacks when they are often signs of progress.
Improvement takes time
Nerve recovery is slow. A reasonable guideline is to allow at least about ten weeks of regular treatment before judging whether nerves are responding, and up to roughly twenty weeks to see how far recovery is likely to go. Early changes, such as returning sensitivity at previously numb points, may appear before the symptoms themselves noticeably improve.
Pain may briefly return as numbness fades
As nerves "wake up," some people pass through a phase where numbness is replaced by tingling, or even pain, before settling into improvement, much like the uncomfortable feeling of a foot waking up after it has fallen asleep. Increased sensation in a previously numb area is generally read as a positive sign, even though it can be unpleasant while it lasts.
Stability matters
Gains depend on the underlying cause staying stable. If blood sugar rises or chemotherapy doses increase, neuropathy can worsen despite treatment. After a course of care, occasional "booster" sessions are sometimes used if symptoms begin to return, particularly for diabetic neuropathy, where the underlying cause is ongoing.
Honest expectations
Acupuncture does not help everyone, and it does not return every case to normal. Across the research, a reasonable expectation is that a meaningful share of patients, often cited around 75%, experience some improvement, but results vary by individual and by type of neuropathy.
Self-care that supports treatment
A few simple measures may support nerve health and, in some cases, treatment progress, particularly for diabetic and idiopathic neuropathy, where improving circulation to the nerves is part of the goal. (For chemotherapy-induced neuropathy, the benefit may be smaller, because the damage is caused directly by neurotoxic drugs.)
Warm foot soaks. Soaking the feet in warm water for 5-10 minutes, often in the evening, is a commonly suggested measure. Anyone with reduced foot sensation should check the water temperature carefully first, to avoid burns.
Gentle sensory stimulation. After soaking and drying, lightly rubbing the soles on a towel or carpet, or using a soft brush, may help stimulate fine nerve fibers and blood flow, most useful in the first few weeks. For the hands, rubbing the palms together to build warmth serves a similar purpose.
Regular, short walks. Two or three brief walks a day are often more practical and better tolerated than a single long one, especially for people with balance problems. Anyone with significant balance or sensation loss should make fall prevention a priority. These measures complement, but do not replace, medical care and acupuncture treatment.
Safety
Acupuncture performed by a licensed, trained practitioner using sterile, single-use needles has a strong safety profile. In the peripheral neuropathy trials reviewed here, side effects were generally minor, soreness, slight bruising, or minor bleeding at needle sites, and serious adverse events were rare. People with reduced sensation, diabetes, or bleeding disorders, and those taking blood thinners, should make sure their practitioner is aware. People with diabetes should continue routine foot care and monitoring throughout. And because identifying and managing the underlying cause of neuropathy is essential, acupuncture should be used alongside, not instead of, evaluation and treatment by a physician.
The bottom line
Peripheral neuropathy is common, and its most frequent forms damage the sensory nerves, producing numbness, tingling, burning, and pain that usually begin in the feet.
Standard medications can ease symptoms but do not repair nerve damage, which has driven interest in additional options.
For diabetic and idiopathic neuropathy, a real and growing body of research, including rigorous trials with objective nerve-conduction measures, supports acupuncture as a way to improve symptoms and, in some studies, nerve function.
For chemotherapy-induced neuropathy the evidence is positive but more mixed; for HIV-associated neuropathy it is not yet established.
Acupuncture is low-risk, works best as a complement to treating the underlying cause, and requires a sustained course of treatment, measured in weeks to months, to give nerves time to respond.
References
Meyer-Hamme G, Friedemann T, Greten J, Gerloff C, Schroeder S. Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: the randomized, partially double-blinded, controlled ACUDIN trial. Journal of Diabetes. 2021;13(6):469-481. pubmed.ncbi.nlm.nih.gov/33150711
Schröder S, et al. Acupuncture treatment improves nerve conduction in peripheral neuropathy. European Journal of Neurology. 2007. Find on PubMed
Acupuncture for sensory symptoms in diabetic peripheral neuropathy. World Journal of Diabetes. 2023. pmc.ncbi.nlm.nih.gov/articles/PMC10055667
Acupuncture-related interventions improve chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis. BMC Complementary Medicine and Therapies. 2024. pubmed.ncbi.nlm.nih.gov/39160496
Xu Z, Wang X, Wu Y, Wang C, Fang X. The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Frontiers in Neurology. 2022;13:963358. frontiersin.org
Yeh M-L, et al. Effects of acupuncture-related intervention on chemotherapy-induced peripheral neuropathy and quality of life: an umbrella review. Complementary Therapies in Medicine. 2025;89:103131. sciencedirect.com
Evans SR, et al. Peripheral neuropathy in HIV: prevalence and risk factors. Find on PubMed
Acupuncture Now Foundation. Acupuncture for Peripheral Neuropathy, research overview and submission to the U.S. Centers for Medicare & Medicaid Services for a National Coverage Determination. acunow.org/acupuncture-for-peripheral-neuropathy
White A, Cummings M, Filshie J, et al. Defining an adequate dose of acupuncture using a neurophysiological approach, a narrative review of the literature. Acupuncture in Medicine. 2008. pubmed.ncbi.nlm.nih.gov/18591910
Liu W-H, Hao Y, Han Y-J, et al. Analysis and thoughts about the negative results of international clinical trials on acupuncture. Evidence-Based Complementary and Alternative Medicine. 2015;2015:671242. ncbi.nlm.nih.gov/pmc/articles/PMC4487698
Lund I, Näslund J, Lundeberg T. Minimal acupuncture is not a valid placebo control in randomised controlled trials of acupuncture: a physiologist's perspective. Chinese Medicine. 2009;4:1. ncbi.nlm.nih.gov/pmc/articles/PMC2644695
A note on this article This article is part of Hope University, an educational resource. Its purpose is to explain and to orient, not to diagnose, treat, or replace the advice of a qualified healthcare provider. Peripheral neuropathy has many possible causes, some of them serious, and identifying the underlying cause is an essential first step. If you are experiencing symptoms, see a physician for evaluation. Any decision to pursue acupuncture should be made with a licensed acupuncturist and in coordination with your medical care.